Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab in clinical practice: managing the risks, enjoying the benefits.
Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders.
Critical role for PDE4 subfamilies in the development of experimental autoimmune encephalomyelitis.
Confounding Psychosis in the Postpartum Period.
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
Lateral ventricular cerebrospinal fluid diffusivity as a potential neuroimaging marker of brain temperature in multiple sclerosis: a hypothesis and implications.
Alemtuzumab for multiple sclerosis: who and when to treat?
Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo.
Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.
Management of optic neuritis as a clinically first event of multiple sclerosis.
Multiple Sclerosis: A Disease of Affluence?.
Role of T cells in neuromyelitis optica.
Persistence of Epstein-Barr Virus in Self-reactive Memory B Cells.
Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory.
Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation.
Quantification of gait kinematics and walking ability of people with multiple sclerosis who are new users of functional electrical stimulation.
Multiple sclerosis: clinical features and MRI findings in Northern China.
Discovery of Dual Leucine Zipper Kinase (DLK, MAP3K12) Inhibitors with Activity in Neurodegeneration Models.
HLA-DRB1 does not have a role in clinical response to interferon-beta among Iranian multiple sclerosis patients.
Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.
Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis.
HMGB1 in Development and Diseases of the Central Nervous System.
Pages
« first
‹ previous
…
264
265
266
267
268
269
270
271
272
…
next ›
last »